Scholars Central

ArticlePublished 30 Apr 2025

Antitumor Effects of Troglitazone and Its Association with Peroxisome Proliferator-Activated Receptor Gamma Activation in FaDu Human Hypopharyngeal Carcinoma Cells

Authors: Thu Do, T T Loan, T D Le, P D Vu, Hoon Yoo

Indian Journal of Pharmaceutical Sciences

Volume 87 · Issue 2 · Pages 59–65

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Troglitazone, originally approved by the Food and Drug Administration for the management of type II diabetes, was later withdrawn due to its severe hepatotoxic effects. In an effort to repurpose Troglitazone, we investigated its potential antitumor effects on FaDu human hypopharyngeal carcinoma cells. Our study found that Troglitazone induced cell cycle arrest at the G2/M phase, which was accompanied by a reduction in key cyclins and cyclin-dependent kinase regulators. Simultaneously, Troglitazone upregulated negative regulators such as p21CIP1/WAF1 and p27KIP1. Furthermore, Troglitazone activated key apoptotic caspases, leading to the cleavage of poly (ADP-ribose) polymerase. These apoptotic responses were mediated through the intrinsic pathway, involving the regulation of both anti-apoptotic and pro-apoptotic factors. Notably, Troglitazone-induced apoptosis was linked to a marked increase in the expr ession of peroxisome proliferator-activated receptor gamma, and this effect was partially reversed by GW9662, a peroxisome proliferator-activated receptor gamma antagonist. In conclusion, our findings suggest that Troglitazone exerts its antitumor effects through peroxisome proliferator-activated receptor gamma activation, making it a promising candidate for repurposing as a therapeutic agent for human hypo pharyngeal car cinoma.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Indian Journal of Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Thu Do”
  • BylineArticles whose byline prints “T T Loan”
  • BylineArticles whose byline prints “T D Le”
  • BylineArticles whose byline prints “P D Vu”
  • BylineArticles whose byline prints “Hoon Yoo”